Document Detail


Adverse effects on cerebral perfusion of prostacyclin administered directly into patients with fulminant hepatic failure and acute renal failure.
MedLine Citation:
PMID:  1758536     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Prior to commencing renal replacement therapy, 8 patients with fulminant hepatic failure and acute renal failure were treated with an infusion of prostacyclin, 5 ng/kg/min, for 30 min, administered directly into the femoral vein. During this period, several adverse effects were noted. There was a reduction in mean arterial blood pressure from a median of 82 (range 65-93) to 67 mm Hg (55-80), p less than 0.01; and an increase in intracranial pressure from a median of 14 (6-33) to 17 mm Hg (6-42), p less than 0.05; with a consequent reduction in cerebral perfusion pressure from a median of 63 (43-77) to 43 mm Hg (15-74), p less than 0.05. There was a reduction in arterial oxygen tension from a median of 19 (13-28) to 16 kPa (12-27), p less than 0.05; and no change in cardiac output, from a median of 6.7 (4.9-11.2) to 6.5 l/min/m2 (3.8-11.0), p greater than 0.05). The administration of prostacyclin into this group of critically ill patients, at risk of death due to cerebral oedema/hypoxia, produced both a reduction in cerebral perfusion pressure and a reduction in total cerebral oxygen delivery.
Authors:
A Davenport; E J Will; A M Davison
Related Documents :
19965926 - Risk factors for hemodynamic instability during surgery for pheochromocytoma.
15721496 - Comparison of transprosthetic mean pressure gradients between medtronic hall and ats va...
15152316 - Natural mercury enrichment in a minerogenic fen--evaluation of sources and processes.
535286 - Intramuscular pressure during walking: an experimental study using the wick catheter te...
7204336 - Rupture of the cell envelope by induced intracellular gas phase expansion in gas vacuol...
290126 - Microvascular pressure in the dental pulp and gingiva in cats.
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Nephron     Volume:  59     ISSN:  0028-2766     ISO Abbreviation:  Nephron     Publication Date:  1991  
Date Detail:
Created Date:  1992-02-06     Completed Date:  1992-02-06     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  0331777     Medline TA:  Nephron     Country:  SWITZERLAND    
Other Details:
Languages:  eng     Pagination:  449-54     Citation Subset:  IM    
Affiliation:
Department of Renal Medicine, St. James's University Hospital, Leeds, UK.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Brain Edema / prevention & control
Cerebrovascular Circulation / drug effects*
Epoprostenol / administration & dosage,  adverse effects*
Female
Femoral Vein
Humans
Hypoxia, Brain / prevention & control
Injections, Intravenous
Kidney Failure, Acute / drug therapy*
Liver Diseases / drug therapy*
Male
Middle Aged
Chemical
Reg. No./Substance:
35121-78-9/Epoprostenol

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Serum Tamm-Horsfall glycoprotein level in children with various renal diseases.
Next Document:  Increases in circulating level of platelet-activating factor lag behind transient neutropenia during...